Structure Therapeutics, Inc. (GPCR)
41.67
+0.42
(+1.02%)
USD |
NASDAQ |
Jun 10, 14:37
Structure Therapeutics EPS Diluted (Quarterly) : -1.052 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Novo Nordisk A/S | 1.709 |
| Viking Therapeutics, Inc. | -1.37 |
| Pfizer Inc. | 0.4688 |
| Tarsus Pharmaceuticals, Inc. | -0.1622 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -76.19M |
| Total Expenses (Quarterly) | 76.19M |
| Enterprise Value | 1.479B |
| Earnings Yield | -6.46% |
| Normalized Earnings Yield | -6.753 |